Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.85), $0.01 better than the analyst estimate of ($0.86). Revenue for the quarter came in at $730 thousand versus the consensus estimate of $1.01 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.